🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
CVS
NYSE
🇺🇸 US
CVS Health Corp.
Healthcare
26Score
DipBuster Score™
$96.07
$0.67 (-0.69%)
Live price · Source: Yahoo
52-Week Position
$69.51
65% of range
$110.68
Beta
0.58
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.58
52W High$110.68
52W Low$69.51
DipBuster Brief
Key signals at a glance
Zone: Hold / Watch
Neutral
Mid-Range Position (65% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position65% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.58
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at CVS Health Corp. (CVS), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-05-31 | Newman Brian | SELL | 2,478 |
| 2026-05-31 | Compton-phillips Amy | SELL | 7,618 |
| 2026-05-21 | Aguirre Fernando | SELL | 1,563 |
| 2026-05-21 | Robbins Larry | SELL | 378,000 |
| 2026-05-21 | Robbins Larry | SELL | 370,462 |
| 2026-05-20 | Aguirre Fernando | SELL | 30,437 |
| 2026-05-20 | Robbins Larry | SELL | 800 |
| 2026-05-20 | Robbins Larry | SELL | 66,881 |
| 2026-05-20 | Robbins Larry | SELL | 152,691 |
| 2026-05-20 | Robbins Larry | SELL | 797,628 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.58
Dividend/yrNone
52W High$110.68
52W Low$69.51
52-Week Range
$69.51Now$110.68
65% through annual range
From 52W High−13.2%
From 52W Low+38.2%
📖 Plain English Summary
CVS Health Corp. is at 65% of its 52-week range. Beta 0.58 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for CVS
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — CVS
Heuristic · balance sheet, insider filings, price data, academic research
CVS Health Corp. — DipBuster Score 26/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track CVS Health Corp. free
Add CVS to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
14/25
Momentum & Volume
7/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
5
/100 · NEUTRAL
dip depth
2/25
oversold rsi
3/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 26/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, an…
Sector
Healthcare
Market
🇺🇸 US
CEO
J. David Joyner
Staff
259,500 employees
Website